Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Clin Cancer Res. 2011 Apr 15;17(13):4550–4557. doi: 10.1158/1078-0432.CCR-11-0116

Figure 2.

Figure 2

Mean telomere length, the number of CD27+ CD8+ cells and the percent persistence of the infused cells in peripheral blood at one month after cell infusion are significantly different in objective responders (CR + PR) compared to non-responders (all p2 < 0.001).